BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 11, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2007
View Archived Issues
AV-411 shows promise as neuropathic pain treatment
Read More
Jerini establishes ophthalmic subsidiary
Read More
Indian researchers present findings on gefitinib and imatinib
Read More
Cleveland BioLabs to submit Protectan CBLB-502 in response to RFP
Read More
Sodium phenylbutyrate to enter clinical evaluation for spinal muscular atrophy
Read More
Recent patent literature covers new drugs for the treatment of immunological disorders.
Read More
New analgesic compounds have been reported in the patent literature
Read More
Evotec collaborates with Boehringer Ingelheim in Alzheimer's disease
Read More
Akesis in-licenses BEOV from U. of British Columbia
Read More
Both PHA-665752 and NK4 inhibit proliferation and migration of CRC cells
Read More
IL-10: A prognostic factor and a target for high-risk melanoma patients
Read More
HEP27: a novel target for selective VTAs
Read More
ChimeriVax-West Nile studied in older adults
Read More
Medtronic and OsteoGenix establish development agreement
Read More
Medistem introduces Tolerostem as second pipeline candidate
Read More
BioLineRx in-licenses BL-4020 for inflammatory disease
Read More
Avera licenses products from Cornell University
Read More
GlycoPEG-GCSF begins second phase I trial
Read More
Amarillo Biosciences updates interferon lozenge trial status
Read More
GW and Otsuka receive Hart-Scott-Rodino clearance for Sativex agreement
Read More
NINDS begins phase III study of PD-02 for Parkinson's disease
Read More
Viral Genetics updates progress in VGV-1 program
Read More
Eisai to acquire Morphotek
Read More
Long-term improvement in BPH patients given NX-1207
Read More
ACP-103 cotherapy provides highly significant antipsychotic efficacy
Read More
Removab may play role in treatment of ascites for non-ovarian cancers
Read More
Coreg CR now available in U.S.
Read More